| UniProt ID | CCL11_HUMAN | |
|---|---|---|
| UniProt AC | P51671 | |
| Protein Name | Eotaxin | |
| Gene Name | CCL11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 97 | |
| Subcellular Localization | Secreted. | |
| Protein Description | In response to the presence of allergens, this protein directly promotes the accumulation of eosinophils, a prominent feature of allergic inflammatory reactions. Binds to CCR3.. | |
| Protein Sequence | MKVSAALLWLLLIAAAFSPQGLAGPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 53 | Phosphorylation | LESYRRITSGKCPQK HHHHHHHCCCCCCCE | 29.61 | - | |
| 54 | Phosphorylation | ESYRRITSGKCPQKA HHHHHHCCCCCCCEE | 33.61 | - | |
| 94 | O-linked_Glycosylation | YLDQKSPTPKP---- HHHHCCCCCCC---- | 51.54 | 9578468 | |
| 94 | O-linked_Glycosylation | YLDQKSPTPKP---- HHHHCCCCCCC---- | 51.54 | 9578468 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CCL11_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCL11_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCL11_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CCL11_HUMAN | CCL11 | physical | 9712872 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| O-linked Glycosylation | |
| Reference | PubMed |
| "Delayed production of biologically active O-glycosylated forms ofhuman eotaxin by tumor-necrosis-factor-alpha-stimulated dermalfibroblasts."; Noso N., Bartels J., Mallet A.I., Mochizuki M., Christophers E.,Schroeder J.-M.; Eur. J. Biochem. 253:114-122(1998). Cited for: GLYCOSYLATION AT THR-94. | |